Overcoming Barriers of Cervical Cancer Elimination in India: A Practice to Policy Level Advocacy.

IF 2 Q3 HEALTH POLICY & SERVICES Journal of Cancer Policy Pub Date : 2024-11-12 DOI:10.1016/j.jcpo.2024.100521
Abhijit Poddar, S R Rao
{"title":"Overcoming Barriers of Cervical Cancer Elimination in India: A Practice to Policy Level Advocacy.","authors":"Abhijit Poddar, S R Rao","doi":"10.1016/j.jcpo.2024.100521","DOIUrl":null,"url":null,"abstract":"<p><p>India's ambitious goal of eliminating cervical cancer by 2030 faces significant challenges due to the high burden of disease, low screening rates, and sociocultural barriers. Despite the Government's focus on vaccination, addressing cervical cancer requires a more comprehensive approach that is multisectoral and consider practice to policy engagement. Addressing not only vaccination but also social barriers, healthcare infrastructure, and research is key to preventing and controlling this preventable disease. Fragmented health policies with limited coverage for cervical cancer, coupled with societal issues like stigma and limited access to healthcare, particularly in rural areas, pose significant challenges. Moreover, limited awareness of HPV and vaccines hinders progress. To effectively combat cervical cancer, India must prioritize a readiness assessment to evaluate past interventions, economic feasibility, and social issues before launching new programs. Improving healthcare infrastructure, training healthcare workers, and utilizing innovative models like mobile clinics can expand access to care. Public-private partnerships with incentives can also play a crucial role in mobilizing resources. Investing in culturally appropriate public awareness campaigns is essential to educate the population about HPV, cervical cancer, and prevention strategies. A robust pharmacovigilance program is necessary to ensure vaccine safety. Additionally, India should invest in science and technology to support long-term research efforts, while increasing understanding of population-specific predisposing factors for broader-spectrum vaccines and personalized approaches. A dedicated national policy with clear objectives, strategies, and accountability mechanisms is crucial for successful cervical cancer control. Learning from the experiences of other countries can inform policy development.</p>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":" ","pages":"100521"},"PeriodicalIF":2.0000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcpo.2024.100521","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

India's ambitious goal of eliminating cervical cancer by 2030 faces significant challenges due to the high burden of disease, low screening rates, and sociocultural barriers. Despite the Government's focus on vaccination, addressing cervical cancer requires a more comprehensive approach that is multisectoral and consider practice to policy engagement. Addressing not only vaccination but also social barriers, healthcare infrastructure, and research is key to preventing and controlling this preventable disease. Fragmented health policies with limited coverage for cervical cancer, coupled with societal issues like stigma and limited access to healthcare, particularly in rural areas, pose significant challenges. Moreover, limited awareness of HPV and vaccines hinders progress. To effectively combat cervical cancer, India must prioritize a readiness assessment to evaluate past interventions, economic feasibility, and social issues before launching new programs. Improving healthcare infrastructure, training healthcare workers, and utilizing innovative models like mobile clinics can expand access to care. Public-private partnerships with incentives can also play a crucial role in mobilizing resources. Investing in culturally appropriate public awareness campaigns is essential to educate the population about HPV, cervical cancer, and prevention strategies. A robust pharmacovigilance program is necessary to ensure vaccine safety. Additionally, India should invest in science and technology to support long-term research efforts, while increasing understanding of population-specific predisposing factors for broader-spectrum vaccines and personalized approaches. A dedicated national policy with clear objectives, strategies, and accountability mechanisms is crucial for successful cervical cancer control. Learning from the experiences of other countries can inform policy development.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
克服印度消除宫颈癌的障碍:从实践到政策层面的宣传。
由于疾病负担重、筛查率低以及社会文化障碍,印度到 2030 年消除宫颈癌的宏伟目标面临着巨大挑战。尽管政府将重点放在疫苗接种上,但解决宫颈癌问题需要采取更全面的多部门方法,并考虑从实践到政策的参与。不仅要解决疫苗接种问题,还要解决社会障碍、医疗保健基础设施和研究问题,这是预防和控制这种可预防疾病的关键。分散的卫生政策对宫颈癌的覆盖面有限,再加上污名化等社会问题以及医疗服务的有限性,尤其是在农村地区,这些都构成了巨大的挑战。此外,人们对人类乳头瘤病毒和疫苗的认识有限,也阻碍了防治工作的进展。为了有效防治宫颈癌,印度必须在启动新计划之前,优先进行准备情况评估,以评估过去的干预措施、经济可行性和社会问题。改善医疗基础设施、培训医疗工作者以及利用流动诊所等创新模式可以扩大医疗服务的覆盖面。有激励措施的公私合作伙伴关系也能在调动资源方面发挥关键作用。投资于适合不同文化背景的提高公众意识活动,对于教育公众了解人乳头瘤病毒、宫颈癌和预防策略至关重要。为确保疫苗的安全性,有必要实施一项强有力的药物警戒计划。此外,印度还应在科技领域进行投资,支持长期研究工作,同时加深对特定人群易感因素的了解,以推广广谱疫苗和个性化方法。一项具有明确目标、战略和问责机制的专门国家政策对于成功控制宫颈癌至关重要。学习其他国家的经验可以为政策制定提供参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Cancer Policy
Journal of Cancer Policy Medicine-Health Policy
CiteScore
2.40
自引率
7.70%
发文量
47
审稿时长
65 days
期刊最新文献
Rapid diagnostic pathways for prostate cancer: A realist synthesis. Time in the U.S. and Colorectal Cancer Screening Adherence Among Diverse Immigrants. Overcoming Barriers of Cervical Cancer Elimination in India: A Practice to Policy Level Advocacy. Precision oncology implementation in a regional-based health care system: A professional consensus to define the pathway Analysis of 810 tweets from 25 unofficial ASCO representatives (Featured Voices) at ASCO 2024
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1